Data / Drug companies / Pyridostigmine bromide
Pyridostigmine bromide: 20 companies and 24 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Pyridostigmine bromide is listed in the FDA National Drug Code Directory by 20 companies, with 24 products in commercial distribution. 18 of the products (75.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; solution; tablet, extended release, and the newest product started marketing on October 9, 2024.
The request: Get every company that lists pyridostigmine bromide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 24
- Generic (ANDA) products
- 18 (75.0%)
- Application numbers
- 17
- Routes
- Oral, Intravenous, Parenteral
- Brand names
- Mestinon, Pryidostigmine Bromide, Regonol, Pryidostigmine Bromide
- openFDA record search
- api.fda.gov
Companies that list pyridostigmine bromide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bausch Health US LLC | 3 | tablet; tablet, extended release | New drug applications (NDA) | January 25, 1965 |
| Amneal Pharmaceuticals of New York LLC | 2 | tablet | Generic drugs (ANDA) | August 8, 2022 |
| Method Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | June 15, 2024 |
| Acella Pharmaceuticals, LLC | 1 | solution | Generic drugs (ANDA) | October 9, 2023 |
| Alvogen Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | June 29, 2015 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | October 4, 2011 |
| Amneal Pharmaceuticals LLC | 1 | tablet, extended release | New drug applications (NDA) | October 9, 2024 |
| Amneal Pharmaceuticals NY LLC | 1 | solution | Generic drugs (ANDA) | January 17, 2020 |
| Ani Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | January 16, 2024 |
| Apnar Pharma LP | 1 | solution | Generic drugs (ANDA) | June 1, 2024 |
| Golden State Medical Supply, Inc. | 1 | tablet | Generic drugs (ANDA) | June 22, 2015 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | August 7, 2015 |
| Novadoz Pharmaceuticals LLC | 1 | solution | Generic drugs (ANDA) | September 21, 2023 |
| Rising Pharma Holdings, Inc. | 1 | tablet | Generic drugs (ANDA) | August 15, 2017 |
| Rising Pharma Holdings, Inc. | 1 | solution | Generic drugs (ANDA) | September 15, 2022 |
| Sandoz Inc | 1 | injection, solution | New drug applications (NDA) | May 10, 2005 |
| Surgeon General-Department of the Army (tsg-Da) | 1 | tablet | New drug applications (NDA) | December 5, 1990 |
| VistaPharm, LLC | 1 | solution | Generic drugs (ANDA) | January 6, 2020 |
| Zydus Lifesciences Limited | 1 | tablet | Generic drugs (ANDA) | August 7, 2015 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet | Generic drugs (ANDA) | August 7, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 13 | 54.2% |
| Solution | 7 | 29.2% |
| Tablet, extended release | 3 | 12.5% |
| Injection, solution | 1 | 4.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 18 | 75% |
| New drug applications (NDA) | 6 | 25% |
Pharmacologic classes
| Class | Products |
|---|---|
| Cholinesterase Inhibitor | 24 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.